GoodRx Inc (PRIVATE.GOODRXINC)

Overall impact
B (61)

Commentary

GoodRx Inc is a strong overall performer. With a 'B' rating of 60.9 for overall impact (64th percentile compared to all companies), GoodRx Inc ranks 16th out of 43 industry peers, behind Pinterest, Adevinta, X (Twitter) and 12 others, and ahead of Kantar Media, BlueCrest, NetEase and 24 others. On top material causes for GoodRx Inc's industry (Interactive Media & Services), GoodRx Inc performs well in Quality Lifelong Education (95.0 score), Racial Justice and Civil Rights (94.9), Equal Pay and Opportunity (82.5) and 2 other causes where it received an 'A' score and performs poorly in Accountable Institutions (0.0 score), Reduced Inequality (38.9), Reduced Waste (28.4) and 3 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.GOODRXINC
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
738
Sector
Communication Services
Industry
Interactive Media & Services
Sub-industry
Interactive Media & Services
SASB industry
Internet Media & Services
Headquarters
#<Country/State:0x00007ce12440f8d0>, United States
Share classes
PRIVATE.GOODRXINC
Description
GoodRx Holdings, Inc. is an American healthcare company that operates a free website and mobile app to compare prescription drug prices across roughly 70,000 U.S. pharmacies, provide coupons and negotiated pricing, and offer telemedicine services to help people find affordable, convenient care.
Material causes
Ethos considers the following causes material for GoodRx Inc, based on its industry sub-industry Interactive Media & Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.